Amisha N.

Amisha N. holds a distinguished career in analytical development and quality control within the biopharmaceutical industry, currently serving as Executive Director at Coherus BioSciences since September 2020. Prior to this, Amisha served as Sr. Director at Dermira, Inc., overseeing biologics analytical development and clinical quality control, where significant contributions included leading the analytical efforts for the Fast Track designated drug Lebrikizumab. Amisha's experience extends across various prestigious companies, including Pfizer and Astellas Pharma, focusing on biosimilar programs, method development, and regulatory submissions. With advanced degrees in protein biochemistry and biophysics, Amisha has authored multiple publications, developed innovative methods, and demonstrated exceptional leadership in building analytical teams and exceeding revenue targets in analytics.